Bio Green Med Solution, Inc. (NasdaqCM: BGMS)
Health Care · Biotechnology · MY
$0.90
+3.91% today · -89.2% 1Y
Bio Green Med Solution, Inc. (NasdaqCM: BGMS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.73M and employs 12 people.
Over the last twelve months the share price has lost 89.2%, trading between 0.57 and 9.40.
Tweenvest scores Bio Green Med Solution, Inc. across four factors: quality 27/100, value 76/100. Its strongest factor is value.
BGMS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.73M
- Revenue (TTM)
- $1.86M
- P/E
- —
- EPS
- -2.95
- Dividend yield
- —
- Beta (5Y)
- -0.40
- 52-week high
- $9.40
- 52-week low
- $0.57
- Avg volume (3M)
- —
- Shares outstanding
- 6.62M
- Employees
- 12
- Next earnings
- —
About Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.
- ISIN
- US23254L8761
- Founded
- 1996
- Listed since
- Sep 12, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $262.85 | -1.11% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.11 | -0.48% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.03 | -0.50% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $549.73 | -0.56% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $818.74 | -1.78% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $148.45 | -6.54% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.